Cargando…
Nivolumab-induced Vogt-Koyanagi-Harada-like Syndrome and Adrenocortical Insufficiency with Long-term Survival in a Patient with Non-small-cell Lung Cancer
A 58-year-old man was diagnosed with lung adenocarcinoma with a tumor proportion score of 10%. After six cycles of second-line chemotherapy with nivolumab, he achieved a complete response (CR) but developed uveitis and sensorineural hearing disorder, which were consistent with Vogt-Koyanagi-Harada (...
Autores principales: | Ushio, Ryota, Yamamoto, Masaki, Miyasaka, Atsushi, Muraoka, Tatsuya, Kanaoka, Hiromi, Tamura, Hironori, Kaneko, Ayami, Izawa, Ami, Hirama, Nobuyuki, Teranishi, Shuhei, Manabe, Saki, Inoue, Tatsuya, Shibata, Kunihiko, Sugiura, Yasuyuki, Kudo, Makoto, Kaneko, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666209/ https://www.ncbi.nlm.nih.gov/pubmed/34092725 http://dx.doi.org/10.2169/internalmedicine.6410-20 |
Ejemplares similares
-
Treatment of Vogt-Koyanagi-Harada Disease
por: Alaql, Musab K, et al.
Publicado: (2020) -
Tofacitinib in Vogt-Koyanagi-Harada disease
por: Dutta Majumder, Parthopratim, et al.
Publicado: (2020) -
An Unusual Presentation of Vogt–Koyanagi–Harada
por: Ipek, Sefik Can, et al.
Publicado: (2021) -
Vogt-Koyanagi-Harada Disease and COVID
por: Manni, Priscilla, et al.
Publicado: (2023) -
Rituximab in refractory Vogt–Koyanagi–Harada disease
por: Dolz-Marco, Rosa, et al.
Publicado: (2011)